Carmichael Hill & Associates, Inc. Moderna, Inc. Call Options Transaction History

Carmichael Hill & Associates, Inc.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 29, 2024	BUY	$63.64 - $125.14 $6,364 - $12,514	100 Added 33.33%	400 $26,000
Q1 2024 Apr 24, 2024	BUY	$85.37 - $115.44 $8,537 - $11,544	100 Added 50.0%	300 $31,000
Q2 2023 Aug 04, 2023	BUY	$118.5 - $160.53 $11,850 - $16,053	100 Added 100.0%	200 $24,000
Q1 2023 Apr 05, 2023	SELL	$135.66 - $197.02 $40,698 - $59,106	-300 Reduced 75.0%	100 $15,000
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $11,838 - $21,004	100 Added 33.33%	400 $71,000
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $32,754 - $55,794	300 New	300 $39,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.